Page 248 - Haematologica Vol. 110 - January 2025
P. 248
LETTER TO THE EDITOR AB
CD
Figure 1. Overall survival predicted by the molecular prognostic risk signature and Krüger’s model in patients with acute myeloid leukemia. (A, B) Overall survival predicted by the molecular prognostic risk signature in patients with newly diagnosed acute myeloid leukemia (A) and in those with relapsed or refractory disease (B). (C) Overall survival according to Krüger’s model in the relapsed/refractory cohort. (D) C-index comparisons. ND: newly diagnosed; mPRS: molecular prognostic risk signature; RR: re- lapsed or refractory; ELN: European LeukemiaNet; OS: overall survival; 95% CI: confidence interval; HR: hazard ratio.
Haematologica | 110 January 2025
240
